Amesite (AMST) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
14 Jul, 2026Opening remarks and agenda
The meeting was called to order at 10:01 A.M. Eastern Time on July 13th, 2026, with a virtual format to increase inclusivity and reach more stockholders.
The business portion was conducted first, followed by a Q&A session for validated stockholders.
Board and executive committee updates
Board members present included J. Michael Losh, Gilbert S. Omenn, Barbie Brewer, and George Parmer.
Sean Reid, outside counsel, acted as secretary, and Sarah Berman served as Inspector of Elections.
Shareholder proposals
Four proposals were presented: election of two Class II directors, ratification of the independent auditor, amendment to the 2018 Equity Incentive Plan, and approval of share issuance related to Series A and A-2 warrants.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Amesite
- Annual meeting seeks approval for director elections, auditor, equity plan, and share issuances.AMST
Proxy filing3 Jun 2026 - Annual meeting to vote on directors, auditor, equity plan amendment, and warrant exercises.AMST
Proxy filing3 Jun 2026 - Auditors flagged going concern risks; offering led by Laidlaw & Company (UK) Ltd.AMST
Registration filing26 May 2026 - Revenue increased and net loss narrowed, but going concern risks persist despite new capital.AMST
Q3 202618 May 2026 - AI healthcare firm offers 4.8M shares for resale, with viability dependent on warrant exercise proceeds.AMST
Registration filing12 May 2026 - Healthcare AI firm offers shares and warrants to fund growth amid ongoing losses and compliance risks.AMST
Registration filing20 Apr 2026 - NurseMagicâ„¢ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026